60 day FRN

Save As...

Reset

Federal Register / Vol. 75, No. 232 / Friday, December 3, 2010 / Notices
on behalf of the Secretary of HHS, to list
as a PSO an entity that attests that it
meets the statutory and regulatory
requirements for listing. A PSO can be
‘‘delisted’’ by the Secretary if it is found
to no longer meet the requirements of
the Patient Safety Act and Patient Safety
Rule, including when a PSO chooses to
voluntarily relinquish its status as a
PSO for any reason.
The directories for both listed
and delisted PSOs are ongoing and
reviewed weekly by AHRQ. The
delisting was effective at 12 Midnight
ET (2400) on October 13, 2010.

DATES:

Both directories can be
accessed electronically at the following
HHS Web site: http://
www.pso.AHRQ.gov/index.html.

FOR FURTHER INFORMATION CONTACT:

Diane Cousins, RPh., Center for Quality
Improvement and Patient Safety, AHRQ,
540 Gaither Road, Rockville, MD 20850;
Telephone (toll free): (866) 403–3697;
Telephone (local): (301) 427–1111; TTY
(toll free): (866) 438–7231; TTY (local):
(301) 427–1130; E-mail:
[email protected].
SUPPLEMENTARY INFORMATION:

mstockstill on DSKH9S0YB1PROD with NOTICES

Background
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity is to
conduct activities to improve patient
safety and the quality of health care
delivery. HHS issued the Patient Safety
Rule to implement the Patient Safety
Act. AHRQ administers the provisions
of the Patient Safety Act and Patient
Safety Rule (PDF file, 450 KB. PDF
Help) relating to the listing and
operation of PSOs. Section 3.108(d) of
the Patient Safety Rule requires AHRQ
to provide public notice when it
removes an organization from the list of
federally approved PSOs. AHRQ has
accepted a notification from Human
Performance Technology Group, Inc.,
PSO number P0003, to voluntarily
relinquish its status as a PSO.
Accordingly, Human Performance
Technology Group, Inc. was delisted
effective at 12 Midnight ET (2400) on
October 13, 2010.
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at http://www.pso.AHRQ.gov/
index.html.

[FR Doc. 2010–30265 Filed 12–2–10; 8:45 am]
BILLING CODE 4160–90–M

VerDate Mar<15>2010

16:09 Dec 02, 2010

Save As...

Jkt 223001

Agency for Healthcare Research and
Quality
Patient Safety Organizations:
Voluntary Delisting
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice of Delisting.
AGENCY:

AHRQ has accepted a
notification of voluntary relinquishment
from Sprixx, a component entity of
Harbor Medical, Inc., of its status as a
Patient Safety Organization (PSO). The
Patient Safety and Quality Improvement
Act of 2005 (Patient Safety Act), Public
Law 109–41, 42 U.S.C. 299b–21—b–26,
provides for the formation of PSOs,
which collect, aggregate, and analyze
confidential information regarding the
quality and safety of health care
delivery. The Patient Safety and Quality
Improvement Final Rule (Patient Safety
Rule), 42 CFR Part 3, authorizes AHRQ,
on behalf of the Secretary of HHS, to list
as a PSO an entity that attests that it
meets the statutory and regulatory
requirements for listing. A PSO can be
‘‘delisted’’ by the Secretary if it is found
to no longer meet the requirements of
the Patient Safety Act and Patient Safety
Rule, including when a PSO chooses to
voluntarily relinquish its status as a
PSO for any reason.
DATES: The directories for both listed
and delisted PSOs are ongoing and
reviewed weekly by AHRQ. The
delisting was effective at 12 Midnight
ET (2400) on October 13, 2010.
ADDRESSES: Both directories can be
accessed electronically at the following
HHS Web site: http://
www.pso.AHRQ.gov/index.html.
FOR FURTHER INFORMATION CONTACT:
Diane Cousins, RPh., Center for Quality
Improvement and Patient Safety, AHRQ,
540 Gaither Road, Rockville, MD 20850;
Telephone (toll free): (866) 403–3697;
Telephone (local): (301) 427–1111; TTY
(toll free): (866) 438–7231; TTY (local):
(301) 427–1130; E-mail:
[email protected].
SUPPLEMENTARY INFORMATION:
SUMMARY:

ADDRESSES:

Dated: November 24, 2010.
Carolyn M. Clancy,
Director.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Background
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity is to
conduct activities to improve patient
safety and the quality of health care
delivery.
HHS issued the Patient Safety Rule to
implement the Patient Safety Act.
AHRQ administers the provisions of the

PO 00000

Frm 00023

Fmt 4703

Sfmt 4703

75473

Patient Safety Act and Patient Safety
Rule (PDF file, 450 KB. PDF Help)
relating to the listing and operation of
PSOs. Section 3.108(d) of the Patient
Safety Rule requires AHRQ to provide
public notice when it removes an
organization from the list of federally
approved PSOs. AHRQ has accepted a
notification from Sprixx, a component
entity of Harbor Medical, Inc., PSO
number P0005, to voluntarily relinquish
its status as a PSO. Accordingly, Sprixx,
a component entity of Harbor Medical,
Inc., was delisted effective at 12:00
Midnight ET (2400) on October 13,
2010.
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at http://www.pso.AHRQ.gov/
index.html.
Dated: November 24, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010–30266 Filed 12–2–10; 8:45 am]
BILLING CODE 4160–90–M

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–11–0775]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Carol Walker, CDC
Reports Clearance Officer, 1600 Clifton
Road, MS–D74, Atlanta, GA 30333 or
send an e-mail to [email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques

E:\FR\FM\03DEN1.SGM

03DEN1

Save As...

75474

Federal Register / Vol. 75, No. 232 / Friday, December 3, 2010 / Notices

or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Formative Research to Develop the
Routine HIV Testing for Emergency
Medicine Physicians, Prevention Is Care
(PIC), and Partner Services Social
Marketing Campaigns—Extension—
(0920–0775, exp. 4/30/2011), National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
This project involves formative
research to inform the development of
three CDC-sponsored social marketing
campaigns: Social Marketing Campaign
to Make HIV Testing a Routine Part of
Medical Care for Emergency Medicine
Physicians (Routine HIV Testing),
Prevention Is Care (PIC), and Partner
Services (Partner Services). The goal of

the Routine HIV Testing Campaign is to
increase HIV testing rates among
individuals who receive care through
the emergency department and the
objective of the campaign is to make
HIV testing a routine part of care
provided by emergency medicine
physicians. PIC entails encouraging
primary care physicians (PCP) and
Infectious Disease Specialists who
deliver care to patients living with HIV
to screen their HIV patients for HIV
transmission behaviors and deliver brief
messages on the importance of
protecting themselves and others by
reducing their risky behaviors. The
long-term objective of the campaign is to
establish PIC as the standard of care for
persons living with HIV. The goal of the
Partner Services component of the PIC
social marketing campaign is to make
HIV partner services a routine part of
medical care. Partner services will
greatly enhance the detection and early
referral of individuals with HIV
infection and will greatly reduce the
number of new infections. The study

entails conducting interviews to test
creative materials with a sample of
emergency medicine physicians for
Routine HIV Testing and with PCP and
Infectious Disease Specialists for PIC
and Partner Services. Findings from this
study will be used by CDC and its
partners to inform current and future
program activities.
For Routine HIV Testing, we expect a
total of 36 physicians to be screened
annually for eligibility. Of the 36
physicians who are screened annually,
we expect that 24 will participate in an
interview annually.
For PIC, we expect a total of 81
physicians to be screened annually for
eligibility. Of the 81 physicians who are
screened, we expect that 54 will
participate in an interview annually.
For Partner Services, we expect a total
of 87 physicians to be screened annually
for eligibility. Of the 87 physicians who
are screened, we expect that 58 will
participate in an interview annually.
There are no costs to the respondents
other than their time.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

Average burden
response
(in hours)

Total burden
(in hours)

Form name

Emergency Medicine Physicians ..
Emergency Medicine Physicians ..
Emergency Medicine Physicians ..

36
24
24

1
1
1

10/60
1
10/60

6
24
4

Prevention Is Care ........................
Prevention Is Care ........................
Prevention Is Care ........................
Partner Services ...........................
Partner Services ...........................
Partner Services ...........................

Routine HIV Testing Screener .....
Routine HIV Testing Interview .....
Routine HIV Paper & Pencil Survey.
PIC Screener ................................
PIC Interview ................................
PIC Paper & Pencil Survey ..........
Screener .......................................
Interview .......................................
Paper & Pencil Survey .................

81
54
54
87
58
58

1
1
1
1
1
1

10/60
1
10/60
10/60
1
10/60

14
54
9
15
58
10

Total .......................................

.......................................................

..........................

..........................

..........................

194

Dated: November 29, 2010.
Carol Walker,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2010–30369 Filed 12–2–10; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSKH9S0YB1PROD with NOTICES

Number of
respondents

Type of respondent

National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry (NCEH/ATSDR);
Notice of National Conversation on
Public Health and Chemical Exposures
Leadership Council Meeting
Time and Date: 9 a.m.–5 p.m. EST,
Wednesday, December 15, 2010.

VerDate Mar<15>2010

16:09 Dec 02, 2010

Save As...

Jkt 223001

Location: Washington Plaza Hotel, 10
Thomas Circle, NW., Washington, DC
20005.
Status: Open to the public, on a first
come, first served basis, limited by the
space available. An opportunity for the
public to listen to the meeting by phone
will be available. For information on
observing the meeting in person or by
phone, see ‘‘contact for additional
information’’ below.
Purpose: This is the seventh meeting
of the National Conversation on Public
Health and Chemical Exposures
Leadership Council, which is convened
by RESOLVE, a non-profit independent
facilitator. The National Conversation
on Public Health and Chemical
Exposures is a collaborative initiative
supported by NCEH/ATSDR and
through which many organizations and
individuals are helping develop an

PO 00000

Frm 00024

Fmt 4703

Sfmt 4703

action agenda for strengthening the
Nation’s approach to protecting the
public’s health from harmful chemical
exposures. The Leadership Council
provides overall guidance to the
National Conversation project and is
responsible for issuing the final action
agenda. For additional information on
the National Conversation on Public
Health and Chemical Exposures, visit
this Web site: http://www.atsdr.cdc.gov/
nationalconversation/.
Meeting agenda: The purpose of the
meeting is to discuss the draft action
agenda.
Contact for additional information: If
you would like to receive additional
information on attending this meeting in
person or listening by telephone, please

E:\FR\FM\03DEN1.SGM

03DEN1